Patents Assigned to Phyton Holdings, LLC
-
Patent number: 10822628Abstract: The present invention relates to a method of producing sesquiterpene lactones of the thapsigargin family, the method comprising the steps of: (a) culturing plant cells of the genus Thapsia in a nutrient medium in a suspension cell culture, wherein the cells produce one or more sesquiterpene lactones of the thapsigargin family; and (b) recovering one or more sesquiterpene lactones of the thapsigargin family produced in (a). The present invention further relates to a suspension cell culture comprising plant cells of the genus Thapsia, wherein the plant cells are capable of producing one or more sesquiterpene lactones of the thapsigargin family and to a plant cell biomass comprising plant cells of the genus Thapsia obtained from said suspension cell culture.Type: GrantFiled: December 2, 2014Date of Patent: November 3, 2020Assignee: Phyton Holdings, LLCInventors: Gilbert Gorr, Harald Heckenmüller, David Alexander Ullisch, Jens Stefan Wilke, Yantree Devi Sankar-Thomas
-
Patent number: 10172306Abstract: The present invention relates to a method of producing Ingenol, Ingenol esters and/or Tiglian-3-one derivatives, the method comprising the steps of: (a) culturing plant cells obtained from a plant selected from the family Euphorbiaceae in a nutrient medium in a suspension cell culture, wherein the cells produce Ingenol, one or more Ingenol esters and/or one or more Tiglian-3-one derivatives; and (b) recovering the Ingenol, the one or more Ingenol esters and/or the one or more Tiglian-3-one derivatives produced in (a). The present invention further relates to a plant suspension cell culture, wherein the cells are obtained from a plant selected from the family Euphorbiaceae, and wherein the plant cells produce Ingenol and/or one or more Ingenol ester and/or one or more Tiglian-3-one derivatives.Type: GrantFiled: March 18, 2016Date of Patent: January 8, 2019Assignee: Phyton Holdings, LLCInventors: Gilbert Gorr, David Alexander Ullisch, Yantree Devi Sankar-Thomas, Thomas Selge, Thomas Leibold, Harald Heckenmüller
-
Patent number: 9926287Abstract: A method of crystallizing docetaxel is disclosed. The method comprises (a) combining docetaxel and at least one solubilizing solvent to obtain a solution, wherein the solubilizing solvent is selected from the group consisting of acetone, methyl-tert-butyl ether, tetrahydrofuran (THF), and acetonitrile and (b) adding an anti-solvent to the solution to obtain a crystalline docetaxel, wherein the anti-solvent is water.Type: GrantFiled: November 18, 2016Date of Patent: March 27, 2018Assignee: Phyton Holdings, LLCInventors: Brian A. Bucher, Edward M. Desimone, III, Roland R. Franke, Rex T. Gallagher, Barry J. Hand, Christopher D. Howe, James H. Johnson, John S. Juchum, Marc A. Plante, T.G. Sambandam, Dong S. Yang
-
Publication number: 20180042194Abstract: The present invention relates to a method of producing Ingenol, Ingenol esters and/or Tiglian-3-one derivatives, the method comprising the steps of: (a) culturing plant cells obtained from a plant selected from the family Euphorbiaceae in a nutrient medium in a suspension cell culture, wherein the cells produce Ingenol, one or more Ingenol esters and/or one or more Tiglian-3-one derivatives; and (b) recovering the Ingenol, the one or more Ingenol esters and/or the one or more Tiglian-3-one derivatives produced in (a). The present invention further relates to a plant suspension cell culture, wherein the cells are obtained from a plant selected from the family Euphorbiaceae, and wherein the plant cells produce Ingenol and/or one or more Ingenol ester and/or one or more Tiglian-3-one derivatives.Type: ApplicationFiled: March 18, 2016Publication date: February 15, 2018Applicant: Phyton Holdings, LLCInventors: Gilbert Gorr, David Alexander Ullisch, Yantree Devi Sankar-Thomas, Thomas Selge, Thomas Leibold, Harald Heckenmüller
-
Publication number: 20170275599Abstract: A plant cell having an animal-type sugar chain adding function is provided. The plant cell has an introduced gene encoding an enzyme derived from an animal, and the enzyme can transfer a fucose residue to a reducing terminal acetylglucosamine residue of a sugar chain of a glycoprotein.Type: ApplicationFiled: November 21, 2016Publication date: September 28, 2017Applicant: Phyton Holdings, LLCInventors: Kazuhito Fujiyama, Tatsuji Seki, Naoyuki Taniguchi
-
Patent number: 9574218Abstract: A method for the secretory production of a glycoprotein having a human-type sugar chain, comprising a step of introducing a gene of an enzyme capable of performing a transfer reaction of a galactose residue to a non-reducing terminal acetylglucosamine residue, and a gene of heterologous glycoprotein, to obtain a transformed plant cell, a step of culturing the plant cell, and a step of recovering the culture medium of the plant cell. The method further includes isolating the glycoprotein from the culture medium and contacting the isolated glycoprotein with a sialic acid transferase to add a sialic acid residue attached to the galactose residue in the N-glycan.Type: GrantFiled: April 14, 2014Date of Patent: February 21, 2017Assignee: Phyton Holdings, LLCInventors: Kazuhito Fujiyama, Tatsuji Seki, Toshiomi Yoshida
-
Patent number: 9527825Abstract: Disclosed is a method of crystallizing docetaxel comprising combining docetaxel and at least one solubilizing solvent to obtain a solution, wherein the solubilizing solvent is methylene chloride and adding an anti-solvent to the solution to obtain a crystalline docetaxel, wherein the anti-solvent is water.Type: GrantFiled: February 25, 2016Date of Patent: December 27, 2016Assignee: Phyton Holdings, LLCInventors: Brian A. Bucher, Edward M. Desimone, III, Roland R. Franke, Rex T. Gallagher, Barry J. Hand, Christopher D. Howe, James H. Johnson, John S. Juchum, Marc A. Plante, T. G. Sambandam, Dong S. Yang
-
Publication number: 20160312255Abstract: The present invention relates to a method of producing sesquiterpene lactones of the thapsigargin family, the method comprising the steps of: (a) culturing plant cells of the genus Thapsia in a nutrient medium in a suspension cell culture, wherein the cells produce one or more sesquiterpene lactones of the thapsigargin family; and (b) recovering one or more sesquiterpene lactones of the thapsigargin family produced in (a). The present invention further relates to a suspension cell culture comprising plant cells of the genus Thapsia, wherein the plant cells are capable of producing one or more sesquiterpene lactones of the thapsigargin family and to a plant cell biomass comprising plant cells of the genus Thapsia obtained from said suspension cell culture.Type: ApplicationFiled: December 2, 2014Publication date: October 27, 2016Applicant: Phyton Holdings, LLCInventors: Gilbert Gorr, Harald Heckenmuller, David Alexander Ullisch, Jens Stefan Wilke, Yantree Devi Sankar-Thomas
-
Patent number: 9303004Abstract: Disclosed is a method of crystallizing a taxane comprising combining the taxane and methylene chloride to obtain a solution and adding an anti-solvent to the solution to obtain a crystalline taxane, wherein the anti-solvent is selected from the group consisting of hexane and heptane.Type: GrantFiled: February 24, 2014Date of Patent: April 5, 2016Assignee: Phyton Holdings, LLCInventors: James H. Johnson, T. G. Sambandam, Barry J. Hand, Christopher D. Howe, Roland R. Franke, Brian A. Bucher, John S. Juchum, Rex T. Gallagher, Marc A. Plante, Edward M. Desimone, III, Dong S. Yang
-
Publication number: 20150065714Abstract: The invention relates to the production of alkaloids from Liliaceae cell culture.Type: ApplicationFiled: August 29, 2014Publication date: March 5, 2015Applicant: Phyton Holdings, LLCInventors: Venkatesh SRINIVASAN, Jennifer Alford, Beth Slusar-Place, Charles Swindell, Michael Horn, Khisal Alvi, Gilbert Gorr
-
Publication number: 20150005517Abstract: Disclosed is a method of crystallizing a taxane comprising combining the taxane and methylene chloride to obtain a solution and adding an anti-solvent to the solution to obtain a crystalline taxane, wherein the anti-solvent is selected from the group consisting of hexane and heptane.Type: ApplicationFiled: February 24, 2014Publication date: January 1, 2015Applicant: Phyton Holdings LLCInventors: James H. Johnson, T.G. Sambandam, Barry J. Hand, Christopher D. Howe, Roland R. Franke, Brian A. Bucher, John S. Juchum, Rex T. Gallagher, Marc A. Plante, Edward M. Desimone, III, Dong S. Yang
-
Publication number: 20140377799Abstract: A method for the secretory production of a glycoprotein having a human-type sugar chain, comprising a step of introducing a gene of an enzyme capable of performing a transfer reaction of a galactose residue to a non-reducing terminal acetylglucosamine residue, and a gene of heterologous glycoprotein, to obtain a transformed plant cell, a step of culturing the plant cell, and a step of recovering the culture medium of the plant cell.Type: ApplicationFiled: April 14, 2014Publication date: December 25, 2014Applicant: Phyton Holdings, LLCInventors: Kazuhito Fujiyama, Tatsuji Seki, Toshiomi Yoshida
-
Patent number: 8877501Abstract: The present invention relates to the production of alkaloids from Liliaceae cell culture.Type: GrantFiled: June 18, 2010Date of Patent: November 4, 2014Assignee: Phyton Holdings, LLCInventors: Venkatesh Srinivasan, Jennifer Alford, Beth Slusar-Place, Charles Swindell, Michael Horn, Khisal Alvi, Gilbert Gorr
-
Patent number: 8853370Abstract: The present invention provides a method for manufacturing a glycoprotein having a human-type sugar chain comprising a step in which transformed plant cell is obtained by introducing to a plant cell the gene of glycosyltransfetase and the gene of an exogenous glycoprotein, and a step in which the obtained transformed plant cell is cultivated.Type: GrantFiled: July 11, 2012Date of Patent: October 7, 2014Assignee: Phyton Holdings, LLCInventors: Tatsuji Seki, Kazuhito Fujiyama
-
Patent number: 8735656Abstract: A method for the secretory production of a glycoprotein having a human-type sugar chain, comprising a step of introducing a gene of an enzyme capable of performing a transfer reaction of a galactose residue to a non-reducing terminal acetylglucosamine residue, and a gene of heterologous glycoprotein, to obtain a transformed plant cell, a step of culturing the plant cell, and a step of recovering the culture medium of the plant cell.Type: GrantFiled: September 14, 2012Date of Patent: May 27, 2014Assignee: Phyton Holdings, LLCInventors: Kazuhito Fujiyama, Tatsuji Seki
-
Patent number: 8703982Abstract: Disclosed is a method of crystallizing a taxane comprising combining the taxane and methylene chloride to obtain a solution and adding an anti-solvent to the solution to obtain a crystalline taxane, wherein the anti-solvent is selected from the group consisting of hexane and heptane.Type: GrantFiled: February 12, 2010Date of Patent: April 22, 2014Assignee: Phyton Holdings LLCInventors: Brian A. Bucher, Edward M. Desimone, III, Roland R. Franke, Rex T. Gallagher, Barry J. Hand, Christopher D. Howe, James A. Johnson, John S. Juchum, Marc A. Plante, T. G. Sambandam, Dong S. Yang
-
Publication number: 20130164782Abstract: A method for the secretory production of a glycoprotein having a human-type sugar chain, comprising a step of introducing a gene of an enzyme capable of performing a transfer reaction of a galactose residue to a non-reducing terminal acetylglucosamine residue, and a gene of heterologous glycoprotein, to obtain a transformed plant cell, a step of culturing the plant cell, and a step of recovering the culture medium of the plant cell.Type: ApplicationFiled: September 14, 2012Publication date: June 27, 2013Applicant: Phyton Holdings, LLCInventors: Kazuhito FUJIYAMA, Tatsuji Seki
-
Publication number: 20130040391Abstract: The present invention provides a method for manufacturing a glycoprotein having a human-type sugar chain comprising a step in which transformed plant cell is obtained by introducing to a plant cell the gene of glycosyltransfetase and the gene of an exogenous glycoprotein, and a step in which the obtained transformed plant cell is cultivated.Type: ApplicationFiled: July 11, 2012Publication date: February 14, 2013Applicant: Phyton Holdings, LLC.Inventors: Tatsuji SEKI, Kazuhito Fujiyama
-
Publication number: 20130017582Abstract: This invention provides methods whereby taxol, baccatin III, and other taxol-like compounds, or taxanes, can be produced in very high yield from all known Taxus species, e.g., brevifolia, canadensis, cuspidata, baccata, globosa, floridana, wallichiana, media and chinensis. Particular modifications of culture conditions (i.e., media composition and operating modes) have been discovered to enhance the yield of various taxanes from cell culture of all species of Taxus. Particularly preferred enhancement agents include silver ion or complex, jasmonic acid (especially the methyl ester), auxin-related growth regulators, and inhibitors of the phenylpropanoid pathway, such as 3,4-methylenedioxy-6-nitrocinnamic acid. These enhancement agents may be used alone or in combination with one another or other yield-enhancing conditions. While the yield of taxanes from plant cell culture of T.Type: ApplicationFiled: September 14, 2012Publication date: January 17, 2013Applicant: Phyton Holdings, LLCInventors: Venkataraman BRINGI, Prakash G. Kadkade, Christopher L. Prince, Braden L. Roach
-
Patent number: 8338143Abstract: This invention provides methods whereby taxol, baccatin III, and other taxol-like compounds, or taxanes, can be produced in very high yield from all known Taxus species, e.g., brevifolia, canadensis, cuspidata, baccata, globosa, floridana, wallichiana, media and chinensis. Particular modifications of culture conditions (i.e., media composition and operating modes) have been discovered to enhance the yield of various taxanes from cell culture of all species of Taxus. Particularly preferred enhancement agents include silver ion or complex, jasmonic acid (especially the methyl ester), auxin-related growth regulators, and inhibitors of the phenylpropanoid pathway, such as 3,4-methylenedioxy-6-nitrocinnamic acid. These enhancement agents may be used alone or in combination with one another or other yield-enhancing conditions. While the yield of taxanes from plant cell culture of T.Type: GrantFiled: December 17, 2010Date of Patent: December 25, 2012Assignee: Phyton Holdings, LLCInventors: Venkataraman Bringi, Prakash Kadkade, Christopher Prince, Braden Roach